Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2022

August 2017 | 91 pages | ID: GBF73E05630EN
QYResearch

Abstracts

This report studies the global Carcinoembryonic Antigen (CEA) market, analyzes and researches the Carcinoembryonic Antigen (CEA) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Roche Diagnostics
• Correlogic Systems
• Abbott Diagnostics
• GenWay Biotech
• Quest Diagnostics

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Application, Carcinoembryonic Antigen (CEA) can be split into

• Colorectal
• Pancreatic
• Ovarian
• Breast
• Thyroid Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF CARCINOEMBRYONIC ANTIGEN (CEA)

1.1 Carcinoembryonic Antigen (CEA) Market Overview
  1.1.1 Carcinoembryonic Antigen (CEA) Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Carcinoembryonic Antigen (CEA) Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Carcinoembryonic Antigen (CEA) Market by End Users/Application
  1.3.1 Colorectal
  1.3.2 Pancreatic
  1.3.3 Ovarian
  1.3.4 Breast
  1.3.5 Thyroid Cancer

2 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) COMPETITION ANALYSIS BY PLAYERS

2.1 Carcinoembryonic Antigen (CEA) Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Roche Diagnostics
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Carcinoembryonic Antigen (CEA) Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Correlogic Systems
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Carcinoembryonic Antigen (CEA) Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Abbott Diagnostics
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Carcinoembryonic Antigen (CEA) Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 GenWay Biotech
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Carcinoembryonic Antigen (CEA) Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Quest Diagnostics
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Carcinoembryonic Antigen (CEA) Revenue (Value) (2012-2017)
  3.5.5 Recent Developments

4 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) MARKET SIZE BY APPLICATION (2012-2017)

4.1 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2012-2017)
4.2 Potential Application of Carcinoembryonic Antigen (CEA) in Future
4.3 Top Consumer/End Users of Carcinoembryonic Antigen (CEA)

5 UNITED STATES CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
5.2 United States Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

6 EU CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
6.2 EU Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

7 JAPAN CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
7.2 Japan Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

8 CHINA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

8.1 China Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
8.2 China Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

9 INDIA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

9.1 India Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
9.2 India Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2012-2017)
10.2 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS AND APPLICATION (2017-2022)

11.1 Global Carcinoembryonic Antigen (CEA) Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
  11.1.2 EU Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
  11.1.4 China Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
  11.1.5 India Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2017-2022)
11.2 Global Carcinoembryonic Antigen (CEA) Market Size (Value) by Application (2017-2022)
11.3 The Market Drivers in Future

12 CARCINOEMBRYONIC ANTIGEN (CEA) MARKET DYNAMICS

12.1 Carcinoembryonic Antigen (CEA) Market Opportunities
12.2 Carcinoembryonic Antigen (CEA) Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Carcinoembryonic Antigen (CEA) Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Carcinoembryonic Antigen (CEA) Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Carcinoembryonic Antigen (CEA) Product Scope
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) (2012-2017)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Regions in 2016
Figure United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Application in 2016
Table Key Downstream Customer in Colorectal
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Colorectal (2012-2017)
Table Key Downstream Customer in Pancreatic
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Pancreatic (2012-2017)
Table Key Downstream Customer in Ovarian
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Ovarian (2012-2017)
Table Key Downstream Customer in Breast
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Breast (2012-2017)
Table Key Downstream Customer in Thyroid Cancer
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Thyroid Cancer (2012-2017)
Table Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2016 and 2017)
Figure Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table Roche Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Roche Diagnostics (2012-2017)
Figure Roche Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share in 2016
Table Correlogic Systems Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Correlogic Systems (2012-2017)
Figure Correlogic Systems Carcinoembryonic Antigen (CEA) Business Revenue Market Share in 2016
Table Abbott Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Abbott Diagnostics (2012-2017)
Figure Abbott Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share in 2016
Table GenWay Biotech Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of GenWay Biotech (2012-2017)
Figure GenWay Biotech Carcinoembryonic Antigen (CEA) Business Revenue Market Share in 2016
Table Quest Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Quest Diagnostics (2012-2017)
Figure Quest Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share in 2016
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application (2012-2017)
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2012
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2013
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2014
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2015
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2016
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Carcinoembryonic Antigen (CEA)
Figure United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure United States Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure United States Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure EU Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure EU Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure EU Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure China Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure China Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure China Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure India Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure India Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure India Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2016
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Regions (2017-2022)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Regions (2017-2022)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Regions in 2017
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Regions in 2022
Figure United States Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application (2017-2022)
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2017
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2022